- Home
- IMNN vs DLPN Comparison
IMNN vs DLPN Comparison
Compare IMNN & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- DLPN
- Stock Information
- Founded
- IMNN 1982
- DLPN 1996
- Country
- IMNN United States
- DLPN United States
- Employees
- IMNN N/A
- DLPN N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- DLPN Other Consumer Services
- Sector
- IMNN Health Care
- DLPN Consumer Discretionary
- Exchange
- IMNN Nasdaq
- DLPN Nasdaq
- Market Cap
- IMNN 12.1M
- DLPN 12.6M
- IPO Year
- IMNN 1985
- DLPN N/A
- Fundamental
- Price
- IMNN $6.53
- DLPN $1.08
- Analyst Decision
- IMNN Buy
- DLPN Strong Buy
- Analyst Count
- IMNN 2
- DLPN 1
- Target Price
- IMNN $182.61
- DLPN $5.00
- AVG Volume (30 Days)
- IMNN 244.8K
- DLPN 644.8K
- Earning Date
- IMNN 08-05-2025
- DLPN 08-13-2025
- Dividend Yield
- IMNN N/A
- DLPN N/A
- EPS Growth
- IMNN N/A
- DLPN N/A
- EPS
- IMNN N/A
- DLPN N/A
- Revenue
- IMNN N/A
- DLPN $51,257,243.00
- Revenue This Year
- IMNN N/A
- DLPN $6.57
- Revenue Next Year
- IMNN N/A
- DLPN $18.10
- P/E Ratio
- IMNN N/A
- DLPN N/A
- Revenue Growth
- IMNN N/A
- DLPN 4.84
- 52 Week Low
- IMNN $4.83
- DLPN $0.75
- 52 Week High
- IMNN $41.22
- DLPN $1.78
- Technical
- Relative Strength Index (RSI)
- IMNN 40.89
- DLPN 43.94
- Support Level
- IMNN $6.17
- DLPN $0.99
- Resistance Level
- IMNN $7.21
- DLPN $1.78
- Average True Range (ATR)
- IMNN 0.51
- DLPN 0.11
- MACD
- IMNN 0.14
- DLPN -0.01
- Stochastic Oscillator
- IMNN 20.45
- DLPN 11.39
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.